These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 2427459)
1. Side-effects of sodium valproate, mainly related to its hepatic and pancreatic toxicity. Jimenez-Rodriguezvila M; Caro-Patón A; Conde M; Dueñas-Laita A; Martin-Lorente JL; Fernandez Perez de Villalain MJ; Gonzalez Martinez de Zarate JL; Marañon A Int J Clin Pharmacol Res; 1986; 6(3):217-24. PubMed ID: 2427459 [TBL] [Abstract][Full Text] [Related]
2. Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy. Hynynen J; Pokka T; Komulainen-Ebrahim J; Myllynen P; Kärppä M; Pylvänen L; Kälviäinen R; Sokka A; Jyrkilä A; Lähdetie J; Haataja L; Mäkitalo A; Ylikotila P; Eriksson K; Haapala P; Ansakorpi H; Hinttala R; Vieira P; Majamaa K; Rantala H; Uusimaa J Epilepsia; 2018 Nov; 59(11):2125-2136. PubMed ID: 30255931 [TBL] [Abstract][Full Text] [Related]
3. [Monotherapy with sodium valproate in generalized primary epilepsy. 2d phase: Study of long-term efficacy and tolerance]. Feuerstein J; Revol M; Roger J; Sallou C; Truelle JL; Vercelletto P; Weber M Sem Hop; 1983 Apr; 59(16):1263-74. PubMed ID: 6191393 [TBL] [Abstract][Full Text] [Related]
4. [Sodium valproate (Na VPa) monotherapy in childhood epilepsy ]. Dulac O; Steru D; Rey E; Arthuis M Arch Fr Pediatr; 1982; 39(6):347-52. PubMed ID: 6812534 [TBL] [Abstract][Full Text] [Related]
6. Effects of sodium valproate in 100 children with special reference to weight. Egger J; Brett EM Br Med J (Clin Res Ed); 1981 Aug; 283(6291):577-81. PubMed ID: 6790086 [TBL] [Abstract][Full Text] [Related]
7. Serum total amylase, pancreatic amylase and lipase activities in epileptic children treated with sodium valproate monotherapy. Voudris K; Attilakos A; Katsarou E; Mastroyianni S; Dimou S; Skardoutsou A; Prassouli A; Garoufi A Brain Dev; 2006 Oct; 28(9):572-5. PubMed ID: 16730152 [TBL] [Abstract][Full Text] [Related]
8. Sodium valproate (Epilim) in epilepsy: a trial. Briant RH; Foote SE; Wallis WE N Z Med J; 1978 Dec; 88(626):479-82. PubMed ID: 105332 [TBL] [Abstract][Full Text] [Related]
9. [Influence of age, body weight and dose on sodium valproate plasma concentrations in children with epilepsy]. Jiang Z; Zhang J; Liao HM; Tang JW; Peng QL Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):325-8. PubMed ID: 18554460 [TBL] [Abstract][Full Text] [Related]
10. Serum amylase, pancreatic amylase and lipase concentrations in epileptic children treated with carbamazepine monotherapy. Voudris KA; Attilakos A; Dimou S; Mastroyianni S; Katsarou E; Skardoutsou A; Garoufi A Clin Chim Acta; 2004 Dec; 350(1-2):175-80. PubMed ID: 15530475 [TBL] [Abstract][Full Text] [Related]
12. Side effects of sodium valproate in monotherapy controlled by plasma levels: a study in 88 pediatric patients. Herranz JL; Arteaga R; Armijo JA Epilepsia; 1982 Apr; 23(2):203-14. PubMed ID: 6804224 [TBL] [Abstract][Full Text] [Related]
14. [Depakene (sodium valproate) in the treatment of epilepsy in children and adolescents: efficiency and safety]. Petrukhin AS; Mukhin KIu Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(6):20-7. PubMed ID: 11517881 [TBL] [Abstract][Full Text] [Related]